JAK2 INHIBITORS AND THEIR USE FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND CANCER
摘要
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase activity of JAK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
申请公布号
CA2772616(A1)
申请公布日期
2011.03.10
申请号
CA20102772616
申请日期
2010.09.02
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
PURANDARE, ASHOK V.;GREBINSKI, JAMES W.;HART, AMY;INGHRIM, JENNIFER;SCHROEDER, GRETCHEN;WAN, HONGHE
